click below
click below
Normal Size Small Size show me how
Chap.20 Quiz #15
Pharmacology ll
| Question | Answer |
|---|---|
| anatrozole | Arimidex (hormonal, antiestrogen) |
| exemesstane | Aromasin (hormonal, antiestrogen) |
| letrozole | Femara (hormonal, antiestrogen) |
| tamoxifen | Nolvadex (hormonal, antiestrogen) |
| abiraterone | Zytiga (hormonal, antiandrogen) |
| apalutamide | Erleada (hormonal, antiandrogen) |
| bicalutamide | Casodex (hormonal, antiandrogen) |
| darolutamide | Nubeqa (hormonal, antiandrogen) |
| enzalutamide | Xtandi (hormonal, antiandrogen) |
| flutamide | (hormonal, antiandrogen) |
| nilutamide | Nilandron (hormonal, antiandrogen) |
| goserelin | Zoladex (hormonal, luteinizing) |
| leuprolide | Lupron (hormonal, luteinizing) |
| abemaciclib | Verzenio (hormonal, cyclin dependent kinase 4/6) |
| palbociclib | Ibrance (hormonal, cyclic dependent kinase 4/6) |
| ribociclib | Kisqali (hormonal, cyclic dependent kinase 4/6) |
| lenalidomide | Revlimid (anticancer, angiogenesis) |
| thalidomide | Thalomid (anticancer, angiogenesis) |
| pomalidomide | Pomalyst (anticancer, angiogenesis) |
| afatinib | Gilotrif (anticancer, tyrosine kinase) |
| axitinib | Inlyta (anticancer, tyrosine kinase) |
| cabozantinib | Cabometyx, Cometriq (anticancer, tyrosine kinase) |
| dacomitinib | Vizimpro (anticancer, tyrosine kinase) |
| erlotinib | Tarceva (anticancer, tyrosine kinase) |
| gefitinib | Iressa (anticancer, tyrosine kinase) |
| lapatinib | Tykerb (anticancer, tyrosine kinase) |
| lenvatinib | Lenvima (anticancer, tyrosine kinase) |
| neratinib | Nerlynx (anticancer, tyrosine kinase) |
| osimertinib | Tagrisso (anticancer, tyrosine kinase) |
| pazopanib | Votrient (anticancer, tyrosine kinase) |
| regorafenib | Stivarga (anticancer, tyrosine kinase) |
| sorafenib | Nexavar (anticancer, tyrosine kinase) |
| sunitinib | Sutent (anticancer, tyrosine kinase) |
| vandetanib | Caprelsa (anticancer, tyrosine kinase) |
| obinutuzumab | Gazyva (monoclonal antibody, Anti-CD20) |
| ofatumumab | Arzerra (monoclonal antibody, Anti-CD20) |
| rituximab | Rituxan (monoclonal antibody, Anti-CD20) |
| cetuximab | Erbitux (monoclonal antibody, Anti-CD20) |
| necitumumab | Portrazza (monoclonal antibody, Anti-CD20) |
| panitumumab | Vecitbix (monoclonal antibody, Anti-CD20) |
| ado-trastuzumab emtansine | Kadcyla (monoclonal antibody, Anti-CD20) |
| fam-trastuzumab deruxetcan | Enhertv (monoclonal antibody, Anti-HER2) |
| pertuzumab | Perjeta (monoclonal antibody, Anti-HER2 |
| trastuzumab | Herceptin (monoclonal antibody, Anti-HER2 |
| bevacizumab | Avastin (monoclonal antibody, Anti-VEGF) |
| ramucirumab | Cyramza (monoclonal antibody, Anti-VEGF) |
| ziv-aflibercept | Zaltrap (monoclonal antibody, Anti-VEGF) |
| bosutinib | Bosulif (monoclonal antibody, signal transduction) |
| dasatinib | Sprycel (monoclonal antibody, signal transduction) |
| imatinib | Gleevec (monoclonal antibody, signal transduction) |
| nilotinib | Tasigna (monoclonal antibody, signal transduction) |
| ponatinib | Iclusig (monoclonal antibody, signal transduction) |
| acalabrutinib | Calquence (monoclonal antibody, signal transduction) |
| ibrutinib | Imbruvica (monoclonal antibody, brutons tyrosine kinase) |
| zanubrutinib | Brukinsa (monoclonal antibody, brutons tyrosine kinase) |
| alpelisib | Piqray (monoclonal antibody, Pl3K/AKt pathway inhibitor) |
| idelalisib | Zydelig (monoclonal antibody/Pl3K/AKt pathway inhibitor) |